Feinberg David T 4

What Happened
David T. Feinberg, a director of Edwards Lifesciences Corp. (EW), was granted 3,251 restricted stock units (RSUs) on May 8, 2026. The Form 4 reports the award as an acquisition at $0.00 (grant value shown as $0 on the filing). The RSUs were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and will convert to shares when they vest.

Key Details

• Transaction date: 2026-05-08; transaction code: A (award/grant).
• Grant size: 3,251 RSUs; reported acquisition price: $0.00; total reported value: $0 (per Form 4).
• Vesting: 100% vesting upon the earlier of one year from the grant date or the issuer’s next annual meeting of stockholders (footnote F1).
• Shares owned after transaction: Not disclosed on this Form 4 (the filing notes it only reflects changes in beneficial ownership).
• Filing timeliness: Form filed on the same date (2026-05-08), indicating a timely report.

Context
RSU grants to nonemployee directors are common compensation and do not involve an immediate purchase or sale of stock. These awards become actual shares only after vesting; they should be viewed as compensation rather than an immediate market signal of buying or selling.